News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
238,635 Results
Type
Article (14499)
Company Profile (25)
Press Release (224110)
Section
Business (75275)
Career Advice (718)
Deals (12643)
Drug Delivery (32)
Drug Development (27323)
Employer Resources (20)
FDA (5405)
Job Trends (5246)
News (121273)
Policy (9727)
Tag
Academia (632)
Accelerated approval (2)
Adcomms (4)
Allergies (31)
Alliances (12408)
ALS (32)
Alzheimer's disease (386)
Antibody-drug conjugate (ADC) (54)
Approvals (5492)
Artificial intelligence (58)
Autoimmune disease (5)
Automation (2)
Bankruptcy (103)
Best Places to Work (4117)
BIOSECURE Act (1)
Biosimilars (40)
Biotechnology (23)
Bladder cancer (48)
Brain cancer (20)
Breast cancer (175)
Cancer (1163)
Cardiovascular disease (103)
Career advice (558)
Career pathing (3)
CAR-T (45)
CDC (6)
Cell therapy (129)
Cervical cancer (12)
Clinical research (23568)
Collaboration (232)
Company closure (1)
Compensation (190)
Complete response letters (2)
COVID-19 (688)
CRISPR (16)
C-suite (56)
Cystic fibrosis (24)
Data (1478)
Decentralized trials (1)
Depression (17)
Diabetes (148)
Diagnostics (1996)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (35)
Drug pricing (42)
Duchenne muscular dystrophy (45)
Earnings (51425)
Editorial (13)
Employer branding (5)
Employer resources (16)
Events (38164)
Executive appointments (106)
FDA (6136)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (200)
Gene editing (34)
Generative AI (1)
Gene therapy (125)
GLP-1 (303)
Government (1129)
Grass and pollen (1)
Guidances (291)
Healthcare (5538)
HIV (25)
Huntington's disease (14)
IgA nephropathy (13)
Immunology and inflammation (50)
Immuno-oncology (3)
Indications (10)
Infectious disease (753)
Inflammatory bowel disease (47)
Inflation Reduction Act (3)
Influenza (27)
Intellectual property (26)
Interviews (90)
IPO (7160)
IRA (17)
Job creations (1346)
Job search strategy (535)
Kidney cancer (4)
Labor market (26)
Layoffs (125)
Leadership (4)
Legal (2188)
Liver cancer (23)
Longevity (2)
Lung cancer (198)
Lymphoma (100)
Machine learning (2)
Management (4)
Manufacturing (88)
MASH (40)
Medical device (4267)
Medtech (4270)
Mergers & acquisitions (5740)
Metabolic disorders (343)
Multiple sclerosis (30)
NASH (6)
Neurodegenerative disease (44)
Neuropsychiatric disorders (10)
Neuroscience (622)
NextGen: Class of 2025 (1545)
Non-profit (1167)
Now hiring (8)
Obesity (161)
Opinion (51)
Ovarian cancer (36)
Pain (37)
Pancreatic cancer (49)
Parkinson's disease (50)
Partnered (4)
Patents (53)
Patient recruitment (42)
Peanut (14)
People (11487)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase I (6330)
Phase II (9735)
Phase III (8947)
Pipeline (1503)
Policy (49)
Postmarket research (1173)
Preclinical (2543)
Press Release (25)
Prostate cancer (43)
Psychedelics (8)
Radiopharmaceuticals (74)
Rare diseases (109)
Real estate (1648)
Recruiting (7)
Regulatory (7182)
Reports (25)
Research institute (541)
Resumes & cover letters (111)
Rett syndrome (3)
RNA editing (5)
RSV (27)
Schizophrenia (38)
Series A (36)
Series B (31)
Sickle cell disease (22)
Special edition (8)
Spinal muscular atrophy (40)
Sponsored (7)
Startups (829)
Stomach cancer (2)
Supply chain (18)
Tariffs (18)
The Weekly (13)
Vaccines (236)
Venture capital (12)
Weight loss (114)
Women's health (9)
Worklife (3)
Date
Last 7 days (123)
Last 30 days (511)
Last 365 days (10524)
2025 (7478)
2024 (11769)
2023 (13130)
2022 (17173)
2021 (17520)
2020 (16450)
2019 (13136)
2018 (9727)
2017 (8680)
2016 (7222)
2015 (8938)
2014 (6895)
2013 (5789)
2012 (38164)
2011 (22663)
2010 (5610)
Location
Africa (262)
Alabama (15)
Arizona (59)
Arkansas (4)
Asia (14805)
Australia (2059)
California (2807)
Canada (861)
China (265)
Colorado (112)
Connecticut (135)
Delaware (101)
Europe (34187)
Florida (373)
Georgia (82)
Idaho (9)
Illinois (230)
India (7)
Indiana (152)
Iowa (2)
Japan (91)
Kansas (64)
Kentucky (14)
Louisiana (10)
Maine (27)
Maryland (304)
Massachusetts (1999)
Michigan (68)
Minnesota (148)
Missouri (33)
Montana (7)
Nebraska (7)
Nevada (34)
New Hampshire (23)
New Jersey (1016)
New Mexico (3)
New York (751)
North Carolina (376)
North Dakota (3)
Northern California (1420)
Ohio (60)
Oklahoma (1)
Oregon (3)
Pennsylvania (597)
Puerto Rico (2)
Rhode Island (6)
South America (394)
South Carolina (10)
Southern California (1063)
Tennessee (33)
Texas (428)
United States (10175)
Utah (74)
Virginia (54)
Washington D.C. (15)
Washington State (231)
Wisconsin (18)
238,635 Results for "13".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
RNA Therapeutics Market Size to Reach USD 26.13 Billion by 2034
September 5, 2025
·
1 min read
Press Releases
Clene to Present at the Emerging Growth Conference - August 13, 2025
August 14, 2025
·
2 min read
Layoffs
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees
Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.
September 11, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Codexis to Report Second Quarter 2025 Financial Results on August 13
July 31, 2025
·
1 min read
Press Releases
Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025
August 8, 2025
·
1 min read
Obesity
Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership
The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new small molecule obesity medications for Lilly.
August 14, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
August 7, 2025
·
1 min read
Press Releases
CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025
August 8, 2025
·
3 min read
Press Releases
Evotec SE to announce first half-year results 2025 on 13 August 2025
August 6, 2025
·
3 min read
1 of 23,864
Next
